To provide one liquid type dental adhesive composition that exhibits excellent adhesive property to glass ceramics, oxide-base ceramics and tooth substance, and has excellent storage stability, which are contrary features. One liquid type dental adhesive composition contains (a) silane coupling agent represented by general formula (1), (b) acidic group-containing polymerizable monomer, (c) volatile organic solvent, and (d) water. ##STR00001##
(In the formula, R.sup.1 represents an organic group having at least one functional group selected from the group consisting of a (meth)acryloyl group, a vinyl group and an epoxy group, R.sup.2 represents C4-C8 linear alkyl group, R.sup.3 represents C1-C8 alkyl group, and n is integer selected from 1 to 3.)

The present application discloses mixed ester terephthalate plasticizer compositions comprising: a compound of formula (I): a compound of formula (II): and a compound of formula (III): wherein R1, R2, and n are defined herein. The present application also discloses resin compositions, insulation layers and cables comprising the plasticizer compositions.

##STR00001##

The present application discloses mixed ester terephthalate plasticizer compositions comprising: a compound of formula (I): a compound of formula (II): and a compound of formula (III): wherein R1, R2, and n are defined herein. The present application also discloses resin compositions, insulation layers and cables comprising the plasticizer compositions.

##STR00001##

The present disclosure relates to injectable and expandable compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely to fill and/or fuse a tissue defect. The present disclosure relates to compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely for bone tissue defect filling/fusion. The design of extendable and expandable compositions for bone fusion is one of the most challenging fields in the intersection of polymer and biomedical engineering. An aspect of the present disclosure relates to an injectable expandable composition for use in medicine, veterinary or cosmetic, comprising a polycaprolactone particle filler; a polydopamine adhesive bound to said filler; a polymethacrylic acid plasticizer bound to said polydopamine adhesive.

The present disclosure relates to injectable and expandable compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely to fill and/or fuse a tissue defect. The present disclosure relates to compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely for bone tissue defect filling/fusion. The design of extendable and expandable compositions for bone fusion is one of the most challenging fields in the intersection of polymer and biomedical engineering. An aspect of the present disclosure relates to an injectable expandable composition for use in medicine, veterinary or cosmetic, comprising a polycaprolactone particle filler; a polydopamine adhesive bound to said filler; a polymethacrylic acid plasticizer bound to said polydopamine adhesive.

The present disclosure relates to injectable and expandable compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely to fill and/or fuse a tissue defect. The present disclosure relates to compositions, devices, kits and methods for use in an approach for the in-situ foaming of polymers for bone or tissue defects, namely for bone tissue defect filling/fusion. The design of extendable and expandable compositions for bone fusion is one of the most challenging fields in the intersection of polymer and biomedical engineering. An aspect of the present disclosure relates to an injectable expandable composition for use in medicine, veterinary or cosmetic, comprising a polycaprolactone particle filler; a polydopamine adhesive bound to said filler; a polymethacrylic acid plasticizer bound to said polydopamine adhesive.

The present invention relates in part to hybrid hydrogel scaffolds including a decellularized extracellular matrix (dECM) tissue, and a synthetic polymer. The dECM may include any suitable tissue including for example, lung tissue, heart tissue, heart-lung block tissue, skin tissue, liver tissue, pancreatic tissue, kidney tissue, and the like.

The present invention relates in part to hybrid hydrogel scaffolds including a decellularized extracellular matrix (dECM) tissue, and a synthetic polymer. The dECM may include any suitable tissue including for example, lung tissue, heart tissue, heart-lung block tissue, skin tissue, liver tissue, pancreatic tissue, kidney tissue, and the like.

Ophthalmic lens comprising an ophthalmic thermoplastic substrate and a light polarizing structure onto said substrate. The ophthalmic lens reduced warpage, in particular when submitted to mechanical, thermal and/or chemical treatment.

Ophthalmic lens comprising an ophthalmic thermoplastic substrate and a light polarizing structure onto said substrate. The ophthalmic lens reduced warpage, in particular when submitted to mechanical, thermal and/or chemical treatment.